<![CDATA[MedTech Founders Club]]>Every medtech device starts with a moment: the one where a founder realized they had something the world needed. The MedTech Founders Club sits down with the people behind those devices to hear that moment — and the story of what came after. Honest conversations about building the technology that's changing healthcare.

]]>https://www.vuelab.com/medtech-founders-clubRiverside.fm (https://riverside.com)Sat, 26 Sep 2026 07:55:06 GMTSat, 27 Jun 2026 10:37:56 GMT60Tim Dingersen<p>Every medtech device starts with a moment: the one where a founder realized they had something the world needed. The MedTech Founders Club sits down with the people behind those devices to hear that moment — and the story of what came after. Honest conversations about building the technology that's changing healthcare.</p>episodicTim Dingersentim@vuelab.comno<![CDATA[Building MedTech marketing from the ground up with no budget. | Jill Later, Cartessa Aesthetics]]>Cartessa Aesthetics started in 2017 with three sales reps and a marketing department of one. Today it has 120 reps across the US and Canada, 4,500 customers, and a practice development team most MedTech companies still don't think to build.

Jill Later, Chief Commercial Officer, was that marketing department of one. In this conversation she goes back to the beginning: no budget, no consistent product photography, a Dropbox full of decks nobody could version, and a founder story she decided to protect from the first day.

What we cover:

The first three years ran with no paid media at all. Every customer who bought a device became a photo, a testimonial, a before-and-after, and eventually a speaker at an event.

Why the first marketing hire isn't a CMO from a big company. It's someone dangerous enough to write, design, and get into the back end of an ad platform themselves.

KOLs without a budget: the founder's relationships, the people who want to be first, and why offering a device for 90 days beats a check.

Post-sale support as the business model. Cartessa hired practice development before it hired its third rep, and it's still where repeat business comes from.

AI as a gut check, not a replacement for thinking, and why someone in every company will soon have to own the guardrails.

Launching into the most crowded category in aesthetics, and why you can't build a device story without providers who've already made money with it.

Jill's one piece of advice for anyone stepping into a MedTech marketing role for the first time.

]]>3456a5f8-2916-445c-94bc-8df8455b6da8Fri, 18 Sep 2026 16:00:22 GMT<p>Cartessa Aesthetics started in 2017 with three sales reps and a marketing department of one. Today it has 120 reps across the US and Canada, 4,500 customers, and a practice development team most MedTech companies still don't think to build.</p><p></p><p>Jill Later, Chief Commercial Officer, was that marketing department of one. In this conversation she goes back to the beginning: no budget, no consistent product photography, a Dropbox full of decks nobody could version, and a founder story she decided to protect from the first day.</p><p></p><p>What we cover:</p><p>The first three years ran with no paid media at all. Every customer who bought a device became a photo, a testimonial, a before-and-after, and eventually a speaker at an event.</p><p></p><p>Why the first marketing hire isn't a CMO from a big company. It's someone dangerous enough to write, design, and get into the back end of an ad platform themselves.</p><p></p><p>KOLs without a budget: the founder's relationships, the people who want to be first, and why offering a device for 90 days beats a check.</p><p></p><p>Post-sale support as the business model. Cartessa hired practice development before it hired its third rep, and it's still where repeat business comes from.</p><p></p><p>AI as a gut check, not a replacement for thinking, and why someone in every company will soon have to own the guardrails.</p><p></p><p>Launching into the most crowded category in aesthetics, and why you can't build a device story without providers who've already made money with it.</p><p></p><p>Jill's one piece of advice for anyone stepping into a MedTech marketing role for the first time.</p>yes00:44:463Building MedTech marketing from the ground up with no budget. | Jill Later, Cartessa Aestheticsfull<![CDATA[The military funded it. Now it could save your life. | Boutwell & Rodenhaver, Envello Medical]]>A wireless sensor the size of a matchbook, built to keep soldiers alive on the battlefield, is now being pointed at heart failure patients in American hospitals.

Casey Boutwell and Dan Rodenhaver join The MedTech Founders Club to tell the story behind Envello Medical.

]]>24b49e5d-1af0-458f-892c-0e154fb2c3d1Sat, 15 Aug 2026 11:00:00 GMT<p>A wireless sensor the size of a matchbook, built to keep soldiers alive on the battlefield, is now being pointed at heart failure patients in American hospitals.</p><p></p><p>Casey Boutwell and Dan Rodenhaver join The MedTech Founders Club to tell the story behind Envello Medical.</p>yes00:55:48The military funded it. Now it could save your life. | Boutwell & Rodenhaver, Envello Medicalfull<![CDATA[How a single VA appointment became an AI startup. | Doug Benoit, FacialDx]]>Six months to wait. Seven minutes to be seen.

That's the VA appointment that started everything for Doug Benoit. After nearly 24 years in the U.S. military — Marine Corps at seventeen, Army intelligence officer through three campaigns — Doug came home with PTSD and a traumatic brain injury. What he didn't expect was that the system meant to take care of him couldn't actually see him.

So he built something that could.

In episode 1 of The MedTech Founders Club, Doug shares how a six-month wait at the VA, a 90-day road trip across America with twenty-two of the veterans he served with, and a question that wouldn't go away became FacialDx — a non-invasive AI screening platform that identifies 156 biomarkers from a series of facial photographs.

What you'll hear:
• Why the screening crisis in American medicine is a body count
• What 24 years of service taught Doug about how the system fails the people it's built for
• The 90-day road trip that became FacialDx's first proof
• Why traditional facial diagnostic medicine — practiced for 2,000 years — was missing one thing
• What he wants other medtech founders to know

Learn more about Doug & FacialDx → https://facialdx.com

]]>cac399eb-c6d8-46b4-a544-a6a21b36dfadMon, 29 Jun 2026 18:00:01 GMT<p>Six months to wait. Seven minutes to be seen.</p><p></p><p>That's the VA appointment that started everything for Doug Benoit. After nearly 24 years in the U.S. military — Marine Corps at seventeen, Army intelligence officer through three campaigns — Doug came home with PTSD and a traumatic brain injury. What he didn't expect was that the system meant to take care of him couldn't actually see him.</p><p>So he built something that could.</p><p></p><p>In episode 1 of The MedTech Founders Club, Doug shares how a six-month wait at the VA, a 90-day road trip across America with twenty-two of the veterans he served with, and a question that wouldn't go away became FacialDx — a non-invasive AI screening platform that identifies 156 biomarkers from a series of facial photographs.</p><p></p><p>What you'll hear:<br />• Why the screening crisis in American medicine is a body count<br />• What 24 years of service taught Doug about how the system fails the people it's built for<br />• The 90-day road trip that became FacialDx's first proof<br />• Why traditional facial diagnostic medicine — practiced for 2,000 years — was missing one thing<br />• What he wants other medtech founders to know</p><p></p><p>Learn more about Doug &amp; FacialDx → <a rel="noopener noreferrer nofollow" href="https://facialdx.com" target="_blank">https://facialdx.com</a></p><p></p>yes00:56:571How a single VA appointment became an AI startup. | Doug Benoit, FacialDxfull